​​​​​​​

Recording long-term electrophysiological signals from patients is often difficult due to the complexity of the measurements, the cost of hospitalization, the burden on patients or the lack of availability of specialist physicians. However, these recordings are essential to establish an accurate diagnosis and a care plan, in many pathologies such as epilepsy, cardiovascular diseases and sleep disorders.

​​​​​​​

IF WE SUBMIT CONNECTED CLOTHES TO PATIENTS, CAN WE PROVIDE THEM WITH AMBULATORY PREVENTIVE MEDICINE?

Because we believe that supporting the development of a disruptive technology is key to change the world with a positive impact on health & well being, we have been accelerated Bioserenity for 4 years until 2020.

The french startup has developed some solutions that allow the recording and long-term follow-up of patients, in their usual environment, while respecting the reference measurements (approved medical device). The company is located within the Institut du Cerveau, in Paris, and employs more than 400 scientists, engineers and doctors.

BioSerenity has made it possible to diagnose more than 14,000 patients.

​​​​​​​Together we commit to act for good and achieve the goals defined by the United Nations through the Sustainable Development Goal number 3.

innovation 3dexperience startup SDGs health epilepsy Lifesciences